本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

10.96
-0.3400-3.01%
盤後10.960.00000.00%19:30 EDT
成交量:24.99萬
成交額:274.94萬
市值:3.84億
市盈率:-91.33
高:11.51
開:11.30
低:10.85
收:11.30
52周最高:13.25
52周最低:5.65
股本:3,506.72萬
流通股本:1,988.67萬
量比:0.97
換手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
淨資產收益率:-18.58%
總資產收益率:-1.16%
市淨率:9.06
市盈率(LYR):-32.15

資料載入中...

2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report